LAHORE: BF Biosciences Limited, Pakistan’s pioneering biopharmaceutical manufacturer, has announced the successful launch of its latest innovation, Zeptide® (Tirzepatide) — an advanced treatment for Type 2 Diabetes and Obesity, now available in a convenient, pre-filled syringe format. In a notice sent to PSX today, BFBIO says that Tirzepatide, approved by the US Food and Drug Administration (FDA), is a synthetic …






